Arcturus Therapeutics Holdings (ARCT) Other Non-Current Assets (2018 - 2026)

Arcturus Therapeutics Holdings' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• Quarterly Other Non-Current Assets fell 88.97% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 88.97% YoY) and the FY2025 annual result came in at $1.9 million, changed 0.0% from the prior year.
• Other Non-Current Assets was $2.0 million for Q1 2026 at Arcturus Therapeutics Holdings, up from $1.9 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $22.1 million in Q3 2023 and bottomed at $1.9 million in Q4 2023.
• A 5-year average of $4.1 million and a median of $2.0 million in 2026 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 1842.06% — and 2024, when it sank 91.48%.
• Arcturus Therapeutics Holdings' Other Non-Current Assets stood at $2.1 million in 2022, then retreated by 9.98% to $1.9 million in 2023, then changed by 0.0% to $1.9 million in 2024, then changed by 0.0% to $1.9 million in 2025, then advanced by 7.59% to $2.0 million in 2026.
• Business Quant data shows ARCT's Other Non-Current Assets at $2.0 million in Q1 2026, $1.9 million in Q4 2025, and $1.9 million in Q3 2025.